Glioblastoma Cancer Vaccine ERC1671

Known as: ERC-1671, ERC1671, Gliovac 
A cancer vaccine composed of a combination of autologous glioblastoma (GBM) tumor cells, allogeneic GBM tumor cells, generated from three different… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
AIM ERC1671 is an allogeneic/autologous therapeutic glioblastoma (GBM) vaccine - composed of whole, inactivated tumor cells mixed… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2018
Review
2018
Glioblastoma is the most common form of brain cancer in adults that produces severe damage to the brain leading to a very poor… (More)
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2015
2015
Glioblastoma multiforme (GBM) patients have a poor prognosis. After tumor recurrence statistics suggest an imminent death within… (More)
  • table 1
  • figure 4
Is this relevant?
2015
2015
Glioblastoma multiforme is a highy aggressive tumor that recurs despite resection, focal beam radiation, and temozolamide… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
Is this relevant?
2015
2015
Patients suffering from a glioblastoma multiforme (GBM) present a very poor prognostic. GBM is the most malignant glioma with a… (More)
  • table 1
Is this relevant?
2012
2012
L. Tenenbaum, M. Pouzet, A. Stathopoulos, F. Jurysta, M. Hamdane, B. Avalosse, W. Hermens, J. Verhaagen, C. Rosenbaum, O.C… (More)
  • figure 1.1
  • figure 2.1
  • figure 2.2
  • table 2.1
  • table 3.1
Is this relevant?